2025 Impact Round-Up: Turning Belief into Progress for Follicular Lymphoma
In 2025 the FLF accelerated scientific momentum, strengthened global collaboration, and elevated the patient voice. In her first year as Global CEO, Emma France reflects on the turning points that pushed progress from possibility into action and shares how the FL community is shaping a future where cures become achievable.
Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
The Follicular Lymphoma Foundation at the American Society of Hematology (ASH) Annual Meeting in Orlando, Florida, one of the world’s premier gatherings for groundbreaking hematology research.
Epcoritamab-bysp in Combination with Rituximab and Lenalidomide Approved as Treatment Option for Relapsed or Refractory Follicular Lymphoma in the U.S.
On November 18, 2025, the FDA approved epcoritamab-bysp (EPKINLY®) in combination with rituximab and lenalidomide for adults with relapsed or refractory follicular lymphoma after at least one prior therapy. This approval applies to patients in the United States..
Unlock the Cure Gala 2025 Raises Funds for Vital Research
The Unlock the Cure Gala 2025 brought supporters together to fund vital research and deliver hope for people living with follicular lymphoma.
FLF shines a spotlight on follicular lymphoma at 18-ICML
We are thrilled to announce that the FLF will be taking centre stage at the upcoming 18th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland, from June 17th-21st, 2025.
Two new ASPIRE awards target Biomarker Discovery in Follicular Lymphoma
The Mark Foundation for Cancer Research and the Follicular Lymphoma Foundation have joined forces to co-fund two new ASPIRE Awards focused on developing more personalized treatment strategies for FL.
Welcoming Emma France as FLF’s New Global CEO
The FLF welcomes Emma France as our new Global CEO. With over 20 years of non-profit leadership, Emma will help drive our mission forward with bold action and impactful change.
World Cancer Day 2025: Supporting Follicular Lymphoma Patients
“Treat the person, not just the disease.”
World Cancer Day is on the 4th February. This year’s theme, United by Unique, emphasizes an essential shift in cancer care: putting patients at the heart of every decision.
2024 End of Year Reflections
This year has been transformative, marked by groundbreaking progress in our mission to cure follicular lymphoma.
Unlock the Cure Gala Dinner Raises Over £800,000
We are thrilled to announce that our Unlock the Cure Gala Dinner saw us raise an astounding £800,000 to further our mission of finding a cure for follicular lymphoma.